Fractional microablative CO₂ laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study

Posted March 22, 2018

Menopause_250x331 Pagano T., De Rosa P., Vallone R., Schettini F., Arpino G., Giuliano M., Lauria R., De Santo I., Conforti A., Gallo A.,Nazzaro G., De Placido S., Locci M., De Placido G. Menopause. 2017 Nov 21. Vol. 25, No. 6, 2018. DOI: 10.1097/GME.0000000000001053.

ad_mlt

Recent Posts

$Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms$ Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms
Fractional CO₂ laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.
Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO₂ Laser Treatment
Fractional CO₂ laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?